Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization VRDN - Viridian Therapeutics, Inc.
522 K
LAST VALUE
108.57%
2 YEAR CAGR
13.19%
5 YEAR CAGR
13.41%
10 YEAR CAGR